Cargando…

Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding

PURPOSE: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used in patients with atrial fibrillation (AF) because of their effectiveness in preventing stroke and their better safety, compared with warfarin. However, there are concerns for an increased risk of bleeding associated with c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Min-Taek, Park, Kwang-Yeol, Kim, Myo-Song, You, Seung-Hun, Kang, Ye-Jin, Jung, Sun-Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471076/ https://www.ncbi.nlm.nih.gov/pubmed/32882758 http://dx.doi.org/10.3349/ymj.2020.61.9.741

Ejemplares similares

Review of gastrointestinal bleeding during use of SSRIs combined with use of NSAID
por: Arts, M., et al.
Publicado: (2022)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
por: Saviano, Angela, et al.
Publicado: (2022)

Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs
por: Aagaard, Lise, et al.
Publicado: (2009)

New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2018)

Lack of reversibility for NOACs
por: Al-Kindi, Sadeer
Publicado: (2014)

TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022)

Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Publicado: (2020)

Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014)

The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
por: Udayachalerm, Sariya, et al.
Publicado: (2018)

An audit assessing the monitoring of SSRIS after initiation in children and adolescents
por: McGowan, Ella
Publicado: (2021)

Reversal agents for NOACs: Connecting the dots
por: Dalal, Jamshed, et al.
Publicado: (2016)

Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010)

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis
por: Liu, Fuwei, et al.
Publicado: (2022)

DVT prophylaxis in critical care: role of NOACS
por: Lancé, Marcus D.
Publicado: (2019)

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs
por: Altman, Raul, et al.
Publicado: (2014)

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention
por: Spinoni, Enrico Guido, et al.
Publicado: (2022)

Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011)

Continuing medical education: SSRIs and pregnancy
por: Andrade, Chittaranjan
Publicado: (2010)

Serotonin syndrome: SSRIs are not the only culprit
por: Garel, Nicolas, et al.
Publicado: (2021)

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report
por: Park, Young-Min, et al.
Publicado: (2012)

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic
por: de Veer, A. J. W. M., et al.
Publicado: (2019)

Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2011)

Treatment of 95 post-Covid patients with SSRIs
por: Rus, Carla P., et al.
Publicado: (2023)

SSRI co‐medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010‐2015
por: Sheikh Rezaei, Safoura, et al.
Publicado: (2019)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)

Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial
por: Ockerman, Anna, et al.
Publicado: (2021)

Are NOACs as safe and efficient as VKA regarding thromboembolic prophylaxis and major bleeding in patients with surgical bioprosthesis and atrial fibrillation within 3 months of surgery?
por: Magro, Pedro Lamares, et al.
Publicado: (2022)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada, Eiji, et al.
Publicado: (2015)

Citizen petition: Sexual side effects of SSRIs and SNRIs
por: Healy, David
Publicado: (2018)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
por: Blann, Andrew
Publicado: (2015)

Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease?
por: Yang, Hayang, et al.
Publicado: (2017)

Abstract 28. Novel Oral Anticoagulants (NOACs) in Microsurgery: A Review
por: Yao, Amy, et al.
Publicado: (2017)

Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population
por: Kim, Jungmee, et al.
Publicado: (2015)

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOACs) Study
por: Paciaroni, Maurizio, et al.
Publicado: (2017)

Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
por: Velasquez, Juan C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_88t8kpp5einn9bhn47a0jb6oce